The MEDVi Files - by Brendan Keeler
US$ 21.79
companies innovating in obesity treatment glp-1 drugs 2025 2025’s Breakthrough Treatments: Top & Innovations GLP-1 Drugs: Bridging Satiety, Nutrition,
Description
JAMA Surg (2016) 151(11):104655
Jorsal A, Kistorp C, Holmager P et al (2017) Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)a multicentre, double-blind, randomised, placebo-controlled trial
This is relevant as the drug predominantly used off-label for IIH, acetazolamide, can be poorly tolerated
George has proven to be one of the best decisions I have made in my life
Anti-obesity medications help our patients focus on creating sustainable behaviors that support a healthy weight and lifestyle, without the distractions of hunger and cravings
GLP-1 Receptor Stimulation Preserves Primary Cortical and Dopaminergic Neurons in Cellular and Rodent Models of Stroke and Parkinsonism